Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term Experimental Mammary Neoplasms. Found 7 abstracts

Balaburski GM, Dardes RC, Johnson M, Haddad B, Zhu F, Ross EA, Sengupta S, Klein-Szanto A, Liu H, Lee ES, Kim H, Jordan VC. Raloxifene-stimulated experimental breast cancer with the paradoxical actions of estrogen to promote or prevent tumor growth: a unifying concept in anti-hormone resistance. Int J Oncol. 2010 Aug;37(2):387-98.   PMCID: PMC3023309
Badawi AF, Eldeen MB, Liu Y, Ross EA, Badr MZ. Inhibition of rat mammary gland carcinogenesis by simultaneous targeting of cyclooxygenase-2 and peroxisome proliferator-activated receptor gamma. Cancer Research. 2004 Feb;64(3):1181-9.
Lu S, Zhang X, Badawi AF, El-Sohemy A, Archer MC. Cyclooxygenase-2 inhibitor celecoxib inhibits promotion of mammary tumorigenesis in rats fed a high fat diet rich in n-6 polyunsaturated fatty acids. Cancer letters. 2002 Oct 08;184(1):7-12.
Desaulniers D, Leingartner K, Russo J, Perkins G, Chittim BG, Archer MC, Wade M, Yang J. Modulatory effects of neonatal exposure to TCDD, or a mixture of PCBs, p,p'-DDT, and p-p'-DDE, on methylnitrosourea-induced mammary tumor development in the rat. Environ Health Perspect. 2001 Jul;109(7):739-47.
Le Voyer T, Rouse J, Lu Z, Lifsted T, Williams M, Hunter KW. Three loci modify growth of a transgene-induced mammary tumor: suppression of proliferation associated with decreased microvessel density. Genomics. 2001 Jun 15;74(3):253-61.
Russo J, Russo IH. Atlas and histologic classification of tumors of the rat mammary gland. J Mammary Gland Biol Neoplasia. 2000 Apr;5(2):187-200.
Russo J, Russo IH. Toward a unified concept of mammary carcinogenesis. Prog Clin Biol Res. 1997 Jan;396:1-16.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term Experimental Mammary Neoplasms

Female Experimental Mammary Neoplasms pathology Animal Rats chemically induced Methylnitrosourea Sprague-Dawley Rats Non-US Gov't Support Cyclooxygenase Inhibitors drug effects Sulfonamides Neoplastic Cell Transformation Breast Cell Division Mice pharmacology Apoptosis Drug Dose-Response Relationship adverse effects Isoenzymes Anticarcinogenic Agents Prostaglandin-Endoperoxide Synthase US Gov't Support-PHS 35661-60-0 (N-(fluorenyl-9-methoxycarbonyl)leucine) Unsaturated Dietary Fats 0 (Sulfonamides) 41598-07-6 (Prostaglandin D2) Cytoplasmic and Nuclear Receptors 0 (Fluorenes) ai [Antagonists & Inhibitors] control 10-Dimethyl-1 9-2-benzanthracene bi [Biosynthesis] Dinoprostone Tumor Cell Line 0 (15-deoxyprostaglandin J2) Drug Interactions Intraductal Carcinoma-Noninfiltrating en [Enzymology] Epithelium 0 (Anticarcinogenic Agents) growth & development prevention & genetics etiology Pregnancy Organochlorine Insecticides 363-24-6 (Dinoprostone) analysis Mammae Environmental Pollutants Drug Synergism Hormonal Antineoplastic Agents Prostaglandin D2 Unsaturated Fatty Acids Blood Vessels Adenocarcinoma Male 0 (Isoenzymes) blood supply DDT Selective Estrogen Receptor Modulators ci [Chemically Induced] 0 (Transcription Factors) me [Metabolism] Estrogens chemically CD31 Antigens In Situ Nick-End Labeling Human ad [Administration & Dosage] US Gov't Support-Non-PHS Neoplasm Drug Resistance Xenograft Model Antitumor Assays EC 1-14-99-1 (Prostaglandin-Endoperoxide Synthase) pd [Pharmacology] Alkylating Agents 61-90-5 (Leucine) de [Drug Effects] pc [Prevention & Control] Polychlorinated Biphenyls Raloxifene Hydrochloride Cell Cycle Genetic Crosses Chromosome Mapping classification Estrogen Antagonists Cytoplasmic and Nuclear) 0 (Receptors 0 (Carcinogens) Ki-67 Antigen Inbred Strains Mice ag [Agonists] physiology Fluorenes 169590-42-5 (celecoxib) Genetic Predisposition to Disease 684-93-5 (Methylnitrosourea) 0 (Cyclooxygenase Inhibitors) Genotype Dietary Fats pharmacokinetics toxicity Puberty aa [Analogs & Derivatives] induced Quantitative Trait Breast Neoplasms EC 1-14-99-1 (cyclooxygenase 2) Leucine Tetrachlorodibenzodioxin DDE Carcinoma ph [Physiology] antagonists & inhibitors therapeutic use Prenatal Exposure Delayed Effects Transcription Factors administration & dosage Cell Proliferation Carcinogens Immunohistochemistry
Last updated on Monday, July 06, 2020